OraPharma
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 42 on the 2024 ''Fortune'' 500 list of the largest United States corporations. In 2024, the company was ranked 45th in the ''Forbes'' Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business segment into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing pharma ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Johnson And Johnson Plaza
Johnson and Johnson Plaza is the world headquarters for Johnson & Johnson in New Brunswick, New Jersey. The 16-story building opened in 1983. Its construction is considered to represent the beginning of revitalization of the city's central business district. Design The complex is situated on a 12-acre downtown site and comprises a 16-story tower and seven connecting three-story modules sheathed in glass and white enameled aluminum. It was designed by Henry N. Cobb from Pei Cobb Freed & Partners. The white tower, one of List of tallest buildings in New Brunswick, tallest buildings in New Brunswick, and surrounding buildings in a park-like setting are across the Northeast Corridor. The buildings were updated in the 2010s following a design by Kimmerle Newman Architects. History The company had historically been located on the Delaware and Raritan Canal in New Brunswick. The company considered moving its headquarters out of New Brunswick in the 1960s, but decided to stay after ci ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Cilag
Cilag AG is a Swiss pharmaceutical company. Cilag is a subsidiary of American pharmaceutical giant Johnson & Johnson. The company is part of Johnson & Johnson Innovative Medicine business segment. Company history In 1933, Swiss chemist Bernhard Joos set up a small research laboratory in Schaffhausen, Switzerland. This set the basis for the founding of ''Chemische Industrie-Labor AG'' (Chemical Industry Laboratory AG or Cilag) on 12 May 1936. The first president of Cilag's administrative board was Carl Naegeli, a well-known professor at the Chemical Institute of the University of Zurich. After the death of Naegeli in 1942, Joos himself then took over the managing role until he left the company in 1949. In 1959, Cilag joined the Johnson & Johnson family of companies. In the early 1990s, the marketing organizations of Cilag and Janssen Pharmaceuticals were joined to form Janssen-Cilag. The non-marketing activities of both companies still operate under their original name. Ci ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Johnson & Johnson Vision
Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson and is composed of two divisions, Johnson & Johnson Surgical Vision and Johnson & Johnson Vision Care (Contact Lens). The company is part of Johnson & Johnson MedTech business segment. Services include Intraocular lenses, laser vision correction systems, phacoemulsification systems, viscoelastic, Microkeratomes and related products used in cataract and refractive surgery. Johnson and Johnson Surgical Vision is based in Santa Ana, California, and Johnson & Johnson Vision Care is based in Jacksonville, Florida. JJV employs approximately 4,200 worldwide. The company has operations in 24 countries and markets products in approximately 60 countries. In February 2017, Abbott Medical Optics changed its name to Johnson & Johnson Vision following its $4.3 billion acquisition by Johnson & Johnson. History In 1959, the contact business unit started as Frontier Contact Lenses in Buffalo, New York. The surgical busine ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Ethicon
Ethicon, Inc., is a subsidiary of Johnson & Johnson. The company is part of the Johnson & Johnson MedTech business segment. It was incorporated as a separate company under the Johnson & Johnson umbrella in 1949 to expand and diversify the Johnson & Johnson product line. Ethicon has manufactured surgical sutures and wound closure devices since 1887. After World War II, Ethicon's market share in surgical sutures rose from 15% to 70% worldwide. In the United States, the market share is approximately 80%. Ethicon conducts business in 52 countries. Corporate history In 1915, George F. Merson opened a facility in Edinburgh for the manufacturing, packaging and sterilising of catgut, silk and nylon sutures. Johnson & Johnson acquired Mr. Merson's company in 1947, and this was renamed Ethicon Suture Laboratories. In 1953 this became Ethicon Inc. In 1992, Ethicon was restructured, and Ethicon Endo-Surgery became a separate corporate entity. In 2008, Ethicon sold its wound manageme ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
DePuy Synthes
DePuy Synthes () is a franchise of orthopaedic and neurosurgery companies. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson MedTech business segment. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands. DePuy Orthopaedics designs, manufactures, markets and distributes products for reconstructing damaged or diseased joints and for repairing and reconstructing traumatic skeletal injuries. DePuy Spine products facilitate fusion of the spine and correction of spinal deformities, preserving motion of the spine and repairing bone fractures. DePuy is now operating from several countries, including the United Kingdom, Japan, France, Germany, Ireland and Australia. In many other countries, DePuy operates as a brand under the Johnson & Johnson Medical organization. DePuy is currently the subject of more than 11,000 lawsuits related to its recall of faulty hip replacement systems, which l ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Biosense Webster
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 42 on the 2024 ''Fortune'' 500 list of the largest United States corporations. In 2024, the company was ranked 45th in the ''Forbes'' Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. In 2023, the company split-off its consumer healthcare business segment into a new publicly traded company, Kenvue. The company is exclusively focused on developing and producing ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Acclarent
Acclarent, Inc. began as a privately held, venture-backed company, and is now a subsidiary of Integra LifeSciences. Based in Irvine, Orange County, California. it develops technology for ENT (Ear, Nose and Throat) related illnesses. History Founded in 2004. Acclarent has over 300 employees and operates in more than 45 countries. Acclarent’s corporate headquarters are located in the Silicon Valley in Menlo Park, California. Since inception, the firm has reported more than $103.5M in funding from its venture partners, New Enterprise Associates (NEA), Versant Ventures, Delphi Ventures, Meritech Capital Partners, and Johnson & Johnson Development Corporation. Acclarent was founded by Joshua Makower who currently serves as Acclarent’s Chairman of the Board. William M. Facteau was the company's President and Chief Operating Officer from November 2004 until March 2012. The company's president is currently Jeff Hopkins. In May 2005, Acclarent received FDA approval for its Rel ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Abiomed
Abiomed, Inc. is a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment. Abiomed develops and manufactures temporary external and implantable mechanical circulatory support devices. The company is headquartered in Danvers, Massachusetts with additional offices in Woburn, Baltimore, Berlin, Aachen, and Tokyo. Andrew Greenfield is President of the company, with Dr. Thorsten Siess as Executive Vice President and Chief Technology Officer and Dr. Chuck Simonton as Executive Vice President and Chief Medical Officer. According to Bloomberg, the company "engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients". As of 2022, the company had secured five FDA approvals and 1,408 patents with 1,416 pending. For fiscal year 2022, Abiomed reported $1.032 billion in revenue and reported diluted earn ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Johnson & Johnson MedTech
Johnson may refer to: People and fictional characters *Johnson (surname), a common surname in English *Johnson (given name), a list of people * List of people with surname Johnson, including fictional characters *Johnson (composer) (1953–2011), Indian film score composer *Johnson (rapper) (born 1979), Danish rapper * Mr. Johnson (born 1966), Nigerian singer Places * Mount Johnson (other) Canada * Johnson, Ontario, township * Johnson (electoral district), provincial electoral district in Quebec * Johnson Point (British Columbia), a headland on the north side of the entrance to Belize Inlet United States * Johnson, Arizona * Johnson, Arkansas, a town * Johnson, Delaware * Johnson, Indiana, an unincorporated town * Johnson, Kentucky * Johnson, Minnesota * Johnson, Nebraska * Johnson, New York * Johnson, Ohio, an unincorporated community * Johnson, Oklahoma * Johnson, Utah * Johnson, Vermont, a town ** Johnson (village), Vermont * Johnson, Washington * Johnson, Wi ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Momenta Pharmaceuticals
Momenta Global Limited (shortened to Momenta) is a developer of intelligent driving technologies, based in Beijing and Suzhou, China. History Momenta was founded in September 2016 led by Cao Xudong, a former scientist at Microsoft Research and formerly executive director of research and development at Chinese deep-learning and computer vision company SenseTime. In 2017, Mercedes-Benz Group invested in Momenta, which was the automaker's first-ever investment into a Chinese startup. Momenta became the first Chinese unicorn in the field of self-driving cars after investors valued the company at more than $1 billion in 2021. The investors included, in addition to those already mentioned, General Motors (GM), IDG Capital, GGV Capital, Blue Lake Capital, Shunwei Capital, and Cathay Capital. General Motors invested $300 million in Momenta, as was announced in 2021, with the aim to accelerate the development of self-driving cars in China. By that time, Momenta struck partnership ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |
|
Janssen Vaccines
Janssen Vaccines, formerly Crucell, is a biotechnology company specializing in vaccines and biopharmaceutical technologies. It was formed when Johnson & Johnson acquired the Dutch biotech company Crucell. Janssen Vaccines is part of Johnson & Johnson Innovative Medicine business segment. __TOC__ History In 1993 Introgene, Crucell's predecessor, was established as a spin-off of Leiden University. The company formed a partnership with Genzyme to collaborate on its vector technology and viral-based products. In 1999 the company founded Galapagos Genomics as a joint venture together with Tibotec. In 2000 IntroGene acquired U-Bisys to form Crucell. In 2006, Crucell and Swiss Berna Biotech; Swedish SBL Vaccines and US-based Berna Products joined forces to become the sixth largest vaccine company worldwide, with their own clinical programs. On 7 January 2009 Crucell released a press release saying Crucell and Wyeth were in discussion on a merger of the two companies. On 26 January ... [...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]   |